Restorative Rehabilitation of the Cleft Affected Occlusion - A Service Evaluation.

Cleft Fixed and Removable Prosthodontics Multidisciplinary Rehabilitation

Journal

The European journal of prosthodontics and restorative dentistry
ISSN: 0965-7452
Titre abrégé: Eur J Prosthodont Restor Dent
Pays: England
ID NLM: 9314899

Informations de publication

Date de publication:
28 Feb 2022
Historique:
pubmed: 14 4 2021
medline: 3 3 2022
entrez: 13 4 2021
Statut: epublish

Résumé

Cleft Lip and/or Palate (CLP) is the most common cranio-facial abnormality thought to be caused by a combination of genetic and environmental factors causing challenges with feeding, dental development and speech. Cleft affected individuals often present a unique set of challenges with regards to their oro-facial and dental development and require multidisciplinary care. This article aims to describe the role of the restorative dentist in the multidisciplinary management of cleft affected individuals and outlines the various clinical presentations and restorative challenges. This article describes the various treatment modalities provided for cleft affected individuals under the National Health Service (NHS) at Liverpool University Dental Hospital (LUDH) and ranges from minimally invasive techniques to conventional fixed and removable prosthodontics.

Identifiants

pubmed: 33848409
doi: 10.1922/EJPRD_2210Lee06
doi:

Types de publication

Journal Article

Langues

eng

Pagination

49-54

Informations de copyright

Copyright© 2022 Dennis Barber Ltd.

Auteurs

Y W J Lee (YWJ)

Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK.

S Kapadia (S)

Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK.

C Butterworth (C)

Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK.

P Thomas (P)

Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK.

P Smith (P)

Liverpool University Dental Hospital, Pembroke Place, Liverpool L3 5PS, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH